I agree that this site is using cookies. You can find further informations here.
X
Nozal, Vanesa
55  results:
Search for persons X
?
1

Designing multitarget ligands for neurodegenerative disease..:

Nozal, Vanesa ; Fernández-Gómez, Paula ; García-Rubia, Alfonso...
Biomedicine & Pharmacotherapy.  175 (2024)  - p. 116626 , 2024
Link: https://doi.org/10.1016/..
 
?
2

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid..:

Martinez-Gonzalez, Loreto ; Cuevas, Eva P. ; Tosat-Bitrián, Carlota...
Frontiers in Molecular Neuroscience.  16 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New..:

Nozal, Vanesa ; Martínez-González, Loreto ; Gomez-Almeria, Marta...
Journal of Medicinal Chemistry.  65 (2022)  2 - p. 1585-1607 , 2022
Link: https://doi.org/10.1021/..
 
?
4

Increasing Brain Permeability of PHA-767491, a Cell Divisio..:

Rojas-Prats, Elisa ; Tosat-Bitrián, Carlota ; Martínez-González, Loreto...
Pharmaceutics.  13 (2021)  2 - p. 180 , 2021
Link: https://doi.org/10.3390/..
 
?
5

From Kinase Inhibitors to Multitarget Ligands as Powerful D..:

Nozal, Vanesa ; García‐Rubia, Alfonso ; Cuevas, Eva P....
Angewandte Chemie.  133 (2021)  35 - p. 19493-19503 , 2021
Link: https://doi.org/10.1002/..
 
?
6

Improved Controlled Release and Brain Penetration of the Sm..:

Nozal, Vanesa ; Rojas-Prats, Elisa ; Maestro, Inés...
International Journal of Molecular Sciences.  22 (2021)  6 - p. 3206 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Host-Directed FDA-Approved Drugs with Antiviral Activity ag..:

Ginex, Tiziana ; Garaigorta, Urtzi ; Ramírez, David...
Pharmaceuticals.  14 (2021)  4 - p. 332 , 2021
Link: https://doi.org/10.3390/..
 
?
8

From Kinase Inhibitors to Multitarget Ligands as Powerful D..:

Nozal, Vanesa ; García‐Rubia, Alfonso ; Cuevas, Eva P....
Angewandte Chemie International Edition.  60 (2021)  35 - p. 19344-19354 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Protein kinase inhibitors for amyotrophic lateral sclerosis..:

Palomo, Valle ; Nozal, Vanesa ; Rojas‐Prats, Elisa..
British Journal of Pharmacology.  178 (2020)  6 - p. 1316-1335 , 2020
Link: https://doi.org/10.1111/..
 
?
10

COVID-19: Drug Targets and Potential Treatments:

Gil, Carmen ; Ginex, Tiziana ; Maestro, Inés...
Journal of Medicinal Chemistry.  63 (2020)  21 - p. 12359-12386 , 2020
Link: https://doi.org/10.1021/..
 
?
11

Tau Tubulin Kinase 1 (TTBK1), a new player in the fight aga..:

Nozal, Vanesa ; Martinez, Ana
European Journal of Medicinal Chemistry.  161 (2019)  - p. 39-47 , 2019
Link: https://doi.org/10.1016/..
 
?
12

TDP-43: A Key Therapeutic Target beyond Amyotrophic Lateral..:

Palomo, Valle ; Tosat-Bitrian, Carlota ; Nozal, Vanesa...
ACS Chemical Neuroscience.  10 (2019)  3 - p. 1183-1196 , 2019
Link: https://doi.org/10.1021/..
 
?
13

Host-directed FDA-approved drugs with antiviral activity ag..:

Ginex, Tiziana ; Garaigorta, Urtzi ; Ramírez, David...
10.3390/ph14040332.  , 2023
Link: https://hdl.handle.net/1..
 
?
14

Compuestos inhibidores de la quinasa de tau y tubulina (TTB..:

Martínez Gil, Ana ; Gil, Carmen ; Nozal, Vanesa...
ES2932481 B2 (2023-09-11).  , 2023
Link: http://hdl.handle.net/10..
 
?
15

TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid..:

Martínez-González, Loreto ; Cuevas, Eva P ; Tosat-Bitrian, Carlota...
#PLACEHOLDER_PARENT_METADATA_VALUE#.  , 2023
Link: http://hdl.handle.net/10..
 
1-15